double-stranded rna sodium salt
Nucleic acidexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jun 9, 2022 (NCT05722691)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- SARS-CoV-2ANTISENSE INHIBITOR
antisense inhibitor - sars-cov-2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05722691 | Phase 3 | Jun 9, 2022 | Promomed, LLC |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Promomed, LLC | For profit | 1 | 1 | 1 | 2022 |
1 organizations
Page 1 / 1